Til hovedinnhold
Norli Bokhandel

The Microbiome and Cancer Treatment - Overcoming Resistance and Enhancing Efficacy

2026, Pocket, Engelsk

2 069,-

Bestillingsvare – sendes normalt innen 10-14 virkedager
  • Ikke tilgjengelig for hent i butikk
The Microbiome and Cancer Treatment: Overcoming Resistance and Enhancing Efficacy delves into the intricate relationship between the microbiome and cancer treatment, highlighting the microbiome's critical role in drug resistance and therapeutic efficacy. The book's chapters are meticulously organized to provide a deep understanding of how the microbiome interacts with the immune system and influences cancer development and response to therapies. This book opens new avenues for investigation by providing a better understanding of the mechanisms of resistance and the role of microbiome alterations in chemoresistance. Sections also address the complex "chicken-or-egg" relationship between microbiome alterations and chemoresistance. A diverse blend of chapters foster interdisciplinary collaboration across fields such as immunology, microbiology, oncology, and pharmacology, promoting holistic approaches to cancer treatment. Readers will benefit by gaining awareness and a better understanding of how the microbiome impacts health, particularly in the context of cancer, leading to more informed health choices.

Produktegenskaper

  • Bidragsyter

    Arun Kumar, M. Pharm Singh (Redaktør) ; Sadhna, PhD. Aggarwal (Redaktør) ; Meenakshi, PhD Dhanawat (Redaktør) ; Garima, MPharm Malik (Redaktør)
  • Forlag/utgiver

    Academic Press Inc
  • Format

    Pocket
  • Språk

    Engelsk
  • Utgivelsesår

    2026
  • Antall sider

    380
  • Utgivelsesdato

    31.12.2026
  • Varenummer

    9780443332067

Kundeanmeldelser

Frakt og levering